Protein-Tyrosine Kinase Inhibition: Mechanism-Based Discovery of Antitumor Agents

Journal of Natural Products
1992.0

Abstract

Protein-tyrosine kinases (PTKs) have been shown to induce the cascade of altered cell parameters characteristic of transformed cells. This proposition provides an important rationale for the discovery of potential antitumor agents from natural sources on the basis of inhibition of PTK activity. Numerous naturally occurring and synthetic analogues of PTK inhibitors were systematically evaluated in this review based on their structure-activity relationships and potential antitumor efficacy.

Knowledge Graph

Similar Paper

Protein-Tyrosine Kinase Inhibition: Mechanism-Based Discovery of Antitumor Agents
Journal of Natural Products 1992.0
Natural products as important tyrosine kinase inhibitors
European Journal of Medicinal Chemistry 2019.0
Naturally Occurring Homoisoflavonoids Function as Potent Protein Tyrosine Kinase Inhibitors by c-Src-Based High-Throughput Screening
Journal of Medicinal Chemistry 2008.0
The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton
Bioorganic & Medicinal Chemistry 2019.0
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
Journal of Medicinal Chemistry 1989.0
Structure-Based Discovery of Small Molecule Inhibitors Targeted to Protein Tyrosine Phosphatase 1B
Journal of Medicinal Chemistry 2000.0
The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms
Bioorganic & Medicinal Chemistry Letters 2009.0
Antitumor studies – Part 2: Structure–activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase
European Journal of Medicinal Chemistry 2008.0
Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues as Potent Cytotoxic Agents
Journal of Medicinal Chemistry 2009.0
Novel Potent Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of 2-Indolinone Derivatives
Journal of Medicinal Chemistry 2010.0